Brain Cancer: Medical Treatments
The question
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with UKRI and the National Institute for Health and Care Research on supporting new and emerging treatments for low‑grade gliomas.
Answered by Dr Zubir Ahmed
The Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR).
Government responsibility for delivering cancer research is shared between Department for Health and Social Care, with research delivered by the NIHR, and Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.
Department of Health and Social Care and Department of Science, Innovation and Technology officials meet regularly to discuss a range of research investments to drive the maximum collective research impact on policy, practice, and individual lives.
The NIHR is continuing to invest in brain tumour research. In December 2025, the NIHR announced the pioneering Brain Tumour Research Consortium to accelerate research into new brain tumour treatments. NIHR is investing an initial £13.7 million in the consortium, with significant further funding due to be awarded early in 2026. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.
The NIHR continues to welcome high quality funding applications for research into any aspect of human health and care, including low-grade glioma.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →